Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) announces the availability of administrative supplements to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Parent awards need not be focused on dietary supplements; this FOA may provide support to include dietary supplements within the scope of relevant research projects. Research interests of ODS are not limited to specific health conditions, organ systems or population groups. ODS supports all types of research, including pre-clinical, clinical, behaviora...
Source: NIDDK Funding Opportunities - June 5, 2018 Category: Endocrinology Source Type: funding
Understanding Skeletal Effects of Type 1 Diabetes (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications for studies to understand the effects of type 1 diabetes (T1D) on bone mass and quality and/or fracture risk. Researchers may propose investigations in newly recruited subjects or using subjects and/or samples from ongoing clinical studies of individuals with for T1D.Saul Malozowski, M.D., Ph.D., M.B.A. | RFA-DK-18-002 (Source: NIDDK Funding Opportunities)
Source: NIDDK Funding Opportunities - May 9, 2018 Category: Endocrinology Source Type: funding
Undergraduate Summer Research Education in Kidney, Urologic, and Hematologic Diseases (R25 Clinical Trial Not Allowed)
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDDK R25 program is to support educational activities that help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences. This FOA solicits applications to establish summer research institutes for qualified undergraduates to participate in summer research e...
Source: NIDDK Funding Opportunities - May 1, 2018 Category: Endocrinology Source Type: funding
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) is to support Exploratory/Developmental Research Grants (R21) that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to kidney disease research. Studies should address important clinical and translational questions and are potentially of high clinical and public health impact. It is anticipated that some projects supported by these grants may lead to full-scale clinical studies including diagnostic strategies, epidemiological studies, or randomized clinical trials of diagnosis, pr...
Source: NIDDK Funding Opportunities - April 4, 2018 Category: Endocrinology Source Type: funding
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) is to support Exploratory/Developmental Research Grants (R21) that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to urologic disorders research. Studies should address important clinical and translational questions that are potentially of high clinical and public health impact. It is anticipated that some projects supported by these grants may lead to full-scale clinical studies including diagnostic strategies, epidemiological studies, or randomized clinical trials of preventi...
Source: NIDDK Funding Opportunities - April 4, 2018 Category: Endocrinology Source Type: funding
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages applications from integrative teams and individual investigators for projects to determine the mechanisms underlying the contribution of these risk-associated genes and their variants for T1D. The purpose is to accelerate the discovery of function of the causal genes and variants that influence the risk for disease.Beena Akolkar Ph.D. | RFA-DK-18-005 (Source: NIDDK Funding Opportunities)
Source: NIDDK Funding Opportunities - April 3, 2018 Category: Endocrinology Source Type: funding
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their...
Source: NIDDK Funding Opportunities - April 3, 2018 Category: Endocrinology Source Type: funding
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases including thyroid, parathyroid and Cushings diseases and acromegaly; and genetic metabolic disease including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases and nutrition; kidney, urologic, and hematologic diseases. The goal of this prog...
Source: NIDDK Funding Opportunities - April 3, 2018 Category: Endocrinology Source Type: funding
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) is calling for R01 grant applications in nonmalignant hematology research. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Aging (NIA) have joined together to build and promote research activities in nonmalignant hematology. Innovative research project applications that will steer the field in new directions are invited. Each project will propose proof of principle research that is tightly focused into one specific aim and is directed at validating novel concepts and...
Source: NIDDK Funding Opportunities - March 29, 2018 Category: Endocrinology Source Type: funding
Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to promote research on food specific molecular signatures and biomarkers of dietary consumption and to promote collaborative interactions among NIH and USDA supported nutrition researchers.Padma Maruvada | PAR-18-727 (Source: NIDDK Funding Opportunities)
Source: NIDDK Funding Opportunities - March 29, 2018 Category: Endocrinology Source Type: funding
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages research grant applications from institutions/organizations that propose to conduct exploratory/developmental clinical studies that will accelerate the development of effective interventions for prevention or treatment of overweight or obesity in adults and/or children. Exploratory epidemiological research with a goal of informing translational/clinical research will also be supported within this program.Robert J. Kuczmarski, Dr.P.H. | PA-18-720 (Source: NIDDK Funding Opportunities)
Source: NIDDK Funding Opportunities - March 27, 2018 Category: Endocrinology Source Type: funding
Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp)
The National Institutes of Health (NIH) Office of the Director announces the availability of administrative supplements to expand existing research to focus on Sexual and Gender Minority (SGM) health. Principal Investigators holding specific types of NIH research grants, listed in the full Funding Opportunity Announcement (FOA) are notified that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but that were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. Applications fo...
Source: NIDDK Funding Opportunities - March 15, 2018 Category: Endocrinology Source Type: funding
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at these applicant institutions. Eligible institutions must award baccalaureate science degrees, and have received less than 6 million dollars per year of NIH support (total costs) in 4 of the last 7 fiscal years.Ms. Aretina Perry-Jones | PAR-18-714 (Source: NIDDK Funding Opportunities)
Source: NIDDK Funding Opportunities - March 14, 2018 Category: Endocrinology Source Type: funding
Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp - Clinical Trial Not Allowed)
The purpose of the administrative supplement is to provide support for NIH-funded investigators to participate in an entrepreneurship training course, the Concept to Clinic: Commercializing Innovation (C3i) Program. The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the...
Source: NIDDK Funding Opportunities - March 6, 2018 Category: Endocrinology Source Type: funding
High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that addresses high priority HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities are described in NOT-OD-15-137: NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding.Peter J. Perrin, Ph.D.;Andrew A. Bremer, M.D., Ph.D.;Paul Kimmel, M.D. | PAS-18-698 (Source: NIDDK Funding Opportunities)
Source: NIDDK Funding Opportunities - March 5, 2018 Category: Endocrinology Source Type: funding
